Industry Maturation and Investment The quantum technology landscape has shifted from experimental research to commercial deployment and industrial application. While the number of funding rounds has decreased, the total capital invested remains robust as investors concentrate on fewer, larger strategic deals favoring companies nearing product delivery. Global government funding has surged, with commitments exceeding $55 billion from nations including the U.S., Japan, and members of the EU, driven by economic opportunity and national security concerns.

Life Sciences and Medicine Healthcare is a primary beneficiary of this revolution. Quantum computing is accelerating drug discovery by performing first-principles simulations of molecular interactions, offering advantages in designing drugs for complex conditi ...